Improving treatments for HIV and tuberculosis in children and vulnerable populations
Mentoring Investigators in HIV and Tuberculosis Therapeutics Research
This study is working to improve treatments for tuberculosis and HIV, especially for children and people living with HIV, by finding better ways to use existing medications and developing new ones that are safe and effective for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11010019 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment options for tuberculosis (TB) and HIV, particularly for children and individuals living with HIV. It aims to develop and optimize new and existing drug regimens to ensure they are effective and safe for all patients, including those with drug-resistant TB. The approach involves using advanced pharmacological techniques to better understand how these drugs work and how they can be used most effectively. By mentoring new researchers in this field, the project seeks to foster innovative patient-oriented research that can lead to improved therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and individuals living with HIV who are at risk of or currently suffering from tuberculosis.
Not a fit: Patients who do not have HIV or tuberculosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment options for patients suffering from HIV and tuberculosis.
How similar studies have performed: Previous research has shown promise in optimizing drug regimens for TB and HIV, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Dooley, Kelly E. — Vanderbilt University Medical Center
- Study coordinator: Dooley, Kelly E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.